Tel: 0207 848 7297

About the study

The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a £2.3m UKRI study jointly led by researchers at the University of Liverpool and King's College London. Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.

Watch the COVID-CNS team discuss the study

The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.


Watch the COVID-CNS team talk about brain complications related to COVID-19 and their findings from the study, one year on from completing recruitment. 

Publications Close up edge of colorful magazine stacking with blurry bookshelf background


The COVID-CNS team are actively producing papers for journals with impact; take a look at the most recent articles.

Patient and public involvement Patient and Public Involvement

Patient and Public Involvement (PPI)

Our PPI panel are helping to shape our research study by sharing the patient’s perspective on COVID-CNS. Find out more from the PPI team.

Latest from @covidcns